HIGH-DOSE CYCLOPHOSPHAMIDE, ETOPOSIDE AND BCNU WITH NON-CRYOPRESERVED AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION FOR POOR PROGNOSIS HODGKIN'S LYMPHOMA

被引:0
|
作者
Brahimi, M. [1 ]
Yafour, N. [1 ]
Osmani, S. [1 ]
Attaf, F. [1 ]
Tadj, H. [1 ]
Arabi, A. [1 ]
Soltan, B. Enta [1 ]
Berredouane, H. [1 ]
Benzineb, B. [1 ]
Bey, M. [1 ]
Bahlat, N. [1 ]
Bekadja, M. A. [1 ]
机构
[1] Univ Hosp Oran 1st November, Oran, Algeria
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1672
引用
收藏
页码:655 / 656
页数:2
相关论文
共 50 条
  • [41] Long-term follow up on patients with Hodgkin lymphoma treated with high-dose BCNU, etoposide, Ara-C, cyclophosphamide and autologous hemopoietic stem cell rescue.
    Gingrich, RD
    Hayashi, M
    Silverman, MM
    Lee, CK
    Hohl, RJ
    Schlueter, A
    BLOOD, 2001, 98 (11) : 392B - 392B
  • [42] Survival benefit front high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma
    Pettengell, R
    Radford, JA
    Morgenstern, GR
    Scarffe, JH
    Harris, M
    Woll, PJ
    Deakin, DP
    Ryder, D
    Wilkinson, PM
    Crowther, D
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) : 586 - 592
  • [43] Idiotype Immunization Following High-Dose Therapy and Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma
    Holman, Peter R.
    Costello, Caitlin
    deMagalhaes-Silverman, Margarida
    Corringham, Sue
    Castro, Januario
    Ball, Edward D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : 257 - 264
  • [44] Idiotype Immunization Following High-Dose Therapy and Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma
    Costello, Caitlin L.
    Holman, Peter
    de Magalhaes-Silverman, Margarida
    Corringham, Sue
    Castro, Januario E.
    Ball, Edward D.
    BLOOD, 2011, 118 (21) : 1724 - 1724
  • [45] BEAM or BuCyE high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients
    Kim, J.
    Kim, E.
    Sohn, B.
    Yoon, D.
    Yoo, C.
    Kim, S.
    Lee, D.
    Kim, S.
    Lee, J.
    Suh, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [46] BEAM OR BUCYE HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION IN NON-HODGKIN'S LYMPHOMA PATIENTS
    Suh, C.
    Kim, J. E.
    Sohn, B. S.
    Yoon, D. H.
    Lee, D. H.
    Kim, S. W.
    Lee, J. S.
    Kim, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 643 - 643
  • [47] A Phase I Trial of High-Dose Clofarabine, Etoposide, and Cyclophosphamide and Autologous Peripheral Blood Stem Cell Transplantation in Patients with Primary Refractory and Relapsed and Refractory Non-Hodgkin Lymphoma
    Srivastava, Shivani
    Jones, David
    Wood, Lisa L.
    Schwartz, Jennifer E.
    Nelson, Robert P., Jr.
    Abonour, Rafat
    Secrest, Angie
    Cox, Elizabeth
    Baute, Jay
    Sullivan, Cheryl
    Kane, Kathleen
    Robertson, Michael.
    Farag, Sherif S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (07) : 987 - 994
  • [48] Risk factors for development of pneumonitis after high-dose chemotherapy with cyclophosphamide, BCNU and etoposide followed by autologous stem cell transplant
    Lane, Andrew A.
    Armand, Philippe
    Feng, Yang
    Neuberg, Donna S.
    Abramson, Jeremy S.
    Brown, Jennifer R.
    Fisher, David C.
    LaCasce, Ann S.
    Jacobsen, Eric D.
    McAfee, Steven L.
    Spitzer, Thomas R.
    Freedman, Arnold S.
    Chen, Yi-Bin
    LEUKEMIA & LYMPHOMA, 2012, 53 (06) : 1130 - 1136
  • [49] Cryopreserved versus non-cryopreserved peripheral blood stem cells for autologous transplantation after high-dose Melphalan in multiple myeloma: comparative analysis
    M. C. B. Bittencourt
    L. Mariano
    F. Moreira
    J. Schmidt-Filho
    A. Mendrone-Jr
    V. Rocha
    Bone Marrow Transplantation, 2019, 54 : 138 - 141
  • [50] High dose therapy and autologous stem cell transplantation in follicular non-Hodgkin's lymphoma
    Freedman, AS
    Gribben, JG
    Nadler, LM
    LEUKEMIA & LYMPHOMA, 1998, 28 (3-4) : 219 - 230